Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors
Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors
Recruiting · NCT07487168 · Registry updated 2026-09-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors | Abdominal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Peritoneal Diseases, appendiceal neoplasm, cecal disorder, cecal neoplasm, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, peritoneal neoplasm, rectal disorder | Recruiting | Phase 1 | 2026-09-16 | NCT07487168 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| H. Lee Moffitt Cancer Center and Research Institute | 162 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Moffitt Cancer Center | Tampa | United States | 523 |